BioPharma Credit PLC Transaction in Own Shares (1342T)
July 15 2020 - 11:30AM
UK Regulatory
TIDMBPCR
RNS Number : 1342T
BioPharma Credit PLC
15 July 2020
BioPharma Credit plc
(the "Company")
TRANSACTION IN OWN SHARES
BioPharma Credit PLC (the "Company") announces that today it has
purchased the following number of its ordinary shares of US$0.01
each on the London Stock Exchange through J.P. Morgan Securities
plc.
Ordinary Shares:
Date of purchase: 15 July 2020
Number of ordinary shares purchased: 22,100
Lowest price per share: $0.994
Highest price per share: $0.996
Trading venue: London Stock Exchange
Aggregate volume per date per trading venue: 22,100
Weighted average price per day per trading venue: $0.9954
The Company intends to hold the purchased shares in
treasury.
Following the above transaction, the Company holds 59,694 of its
ordinary shares in treasury and has 1,373,872,373 ordinary shares
in issue (excluding treasury shares). Therefore, the total number
of voting rights in the Company is 1,373,872,373. This figure may
be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency Rules.
Enquiries
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
+44 (0)1392 477 500
J.P. Morgan Cazenove
+44 (0)20 7742 4000
William Simmonds
Oliver Kenyon
Buchanan
+44 (0)20 7466 5000 / biopharmacredit@buchanan.uk.com
David Rydell
Mark Court
Jamie Hooper
Henry Wilson
Notes to Editors
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
POSQELFFBDLFBBQ
(END) Dow Jones Newswires
July 15, 2020 12:30 ET (16:30 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2023 to Apr 2024